2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
  • United States
  • Canada
  • United Kingdom
Investment stages
  • Series B
  • Series C
  • Growth
Industries
  • Digital Health
  • Health Tech
About
Transformation Capital is a Boston-based growth-stage investor focused entirely on healthcare technology. It partners with digital health companies that have moved past early validation and are scaling commercially. Its team brings operating and commercial experience specific to US healthcare systems.
Min check size
$10M
Max check size
$50M
Fund size
NPS

Investment Thesis

Transformation Capital invests at Series B and later in digital health, on the thesis that healthcare's hardest problem is commercial scaling rather than product invention. It targets companies with proven clinical and revenue traction that need growth capital and healthcare-specific commercial expertise to reach enterprise buyers such as payers, providers and employers.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Founded in 2016 as Leerink Transformation Partners by Todd Cozzens and Jared Kesselheim alongside SVB Leerink, then spun out independent in 2019 with $313M across 12 companies when Mike Dixon joined. Cozzens took Marquette Medical public before its $800M sale to GE, founded and sold Picis to UnitedHealth Group, then co-led digital health at Sequoia; he sits on the Natera board. Kesselheim is Harvard/MGH-trained and led healthcare investing at Bain Capital Ventures for eight years. Dixon spent a decade at Sequoia and previously Fidelity. Kevin Brown, formerly CFO of Leerink Capital, remains the operational leader. Manages $800M+ across five funds, 76 investments and 12 exits, writing $20–100M cheques into commercial-stage companies.

Transformation Capital Contacts Information

Primary contact

Secondary contact

Team

Todd Cozzens-Co-Founder & Managing Partner

Jared Kesselheim-Co-Founder & Managing Partner

Mike Dixon-Managing Partner

Julie Murchinson-Partner

Portfolio

Datavant

Health Catalyst

Sword Health

Capital Rx

Grow Therapy

SmarterDx

CodaMetrix

RadAI

Parachute Health

Local Infusion

Alaffia Health

Kyruus

H1

Olive

RapidSOS

PlushCare

Panalgo

LetsGetChecked

Protenus

PatientPop

PatientPing

Apixio

Natera

DexCare

Groups

Apree Health

Jeenie

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp